```html

Vitreoretinal Disorders – A Complete Guide for Patients

Overview

Vitreoretinal disorders are a group of conditions that affect the vitreous (the clear gel that fills the eye) and the retina (the light‑sensing tissue at the back of the eye). When the vitreous pulls away or adheres abnormally to the retina, it can cause tears, detachments, bleeding, or scarring, leading to vision loss if not treated promptly.

These disorders are most common in adults over 50, but they can also affect younger individuals, especially those with hereditary eye disease, high myopia, or a history of eye injury.

• Prevalence: In the United States, retinal detachment occurs in about 1 in 10,000 people each year, and proliferative diabetic retinopathy affects roughly 4.6 million adults (CDC, 2023).
• Who is affected:
  • Adults > 50 years – natural vitreous degeneration.
  • People with diabetes, high myopia, or prior eye surgery.
  • Individuals with inflammatory or infectious eye diseases (e.g., uveitis, toxoplasmosis).

Symptoms

Because the vitreous is attached to the retina, any abnormal traction can produce distinct warning signs. Not all patients experience every symptom, and early detection is crucial.

Common Symptoms

• Floaters: Small specks, strands, or cobweb‑like shadows that move with eye motion.
• Flashes of light (photopsia): Brief, lightning‑like streaks, especially in peripheral vision.
• Shadow or curtain over part of the visual field: May indicate a retinal tear or detachment.
• Sudden decrease in visual acuity: Blurring or “out‑of‑focus” vision that does not improve with glasses.
• Distorted straight lines (metamorphopsia): Straight edges appear wavy, typical of macular involvement.
• Red or dark spots: May represent hemorrhage or vitreous bleeding.

Less Common but Important Symptoms

• Eye pain or pressure (usually a sign of inflammation or neovascular disease).
• Colour vision changes, especially a loss of vivid reds.
• Pupillary abnormalities (e.g., a “relative afferent pupillary defect”) suggesting optic nerve involvement.

Causes and Risk Factors

Vitreoretinal disorders arise from a combination of age‑related vitreous changes, systemic diseases, and ocular trauma.

Primary Causes

• Posterior Vitreous Detachment (PVD): Natural separation of the vitreous from the retina, which can create tractional forces leading to tears.
• Retinal Tears/Detachment: A full‑thickness break in the retina allows fluid to seep underneath, separating it from the underlying tissue.
• Diabetic Retinopathy: High blood glucose damages retinal vessels, causing leakage, neovascularization, and vitreous hemorrhage.
• Age‑related Macular Degeneration (AMD): In its advanced “wet” form, abnormal blood vessels grow under the retina and can bleed into the vitreous.
• Myopic (Degenerative) Retinal Changes: Extreme nearsightedness stretches the retina, predisposing to tears and detachments.
• Inflammatory or Infectious Conditions: Uveitis, toxoplasmosis, cytomegalovirus, and syphilis can cause vitreoretinal scarring.

Risk Factors

• Age > 50 years (vitreous liquefaction).
• High myopia (≥ -6.00 D).
• History of ocular trauma or prior eye surgery (e.g., cataract extraction, vitrectomy).
• Systemic diabetes mellitus – especially poorly controlled (HbA1c > 7%).
• Family history of retinal detachment or inherited retinal dystrophies.
• Smoking – increases oxidative stress on retinal tissue.
• Connective‑tissue disorders (e.g., Marfan syndrome) that affect vitreous consistency.

Diagnosis

Accurate diagnosis requires a detailed history, comprehensive eye examination, and often imaging studies.

Clinical Evaluation

• Visual acuity testing: To quantify loss.
• Dilated fundus examination: Using binocular indirect ophthalmoscopy to view the peripheral retina and vitreous.
• Slit‑lamp biomicroscopy: For anterior segment and vitreous assessment.

Imaging and Diagnostic Tests

• Optical Coherence Tomography (OCT): Provides high‑resolution cross‑sectional images of the macula and vitreoretinal interface. Essential for detecting macular edema, epiretinal membranes, and subtle detachments.
• Fundus Fluorescein Angiography (FFA): Highlights abnormal retinal blood vessels (e.g., neovascularization in diabetic retinopathy).
• Ultrasound B‑scan: Useful when media opacity (cataract, vitreous hemorrhage) prevents direct view; can detect retinal detachment or foreign bodies.
• Wide‑field retinal imaging: Captures peripheral retina where many tears occur.

Laboratory work may be ordered if an inflammatory or infectious cause is suspected (e.g., syphilis serology, tuberculosis test, ANA panel).

Treatment Options

Management is tailored to the specific disorder, its severity, and the patient’s overall health.

Medications

• Anti‑VEGF agents (e.g., ranibizumab, aflibercept, bevacizumab): Inhibit abnormal blood‑vessel growth in wet AMD and proliferative diabetic retinopathy. Administered via intravitreal injection every 4–12 weeks.
• Corticosteroid implants (e.g., dexamethasone): Reduce macular edema secondary to diabetic retinopathy or retinal vein occlusion.
• Systemic control of diabetes: Tight glycemic control (target HbA1c < 7%) slows progression of diabetic retinopathy.
• Antibiotics/antivirals: Used for infectious vitreoretinitis (e.g., intravitreal ganciclovir for CMV).

Surgical and Procedural Interventions

• Laser Photocoagulation: Burns peripheral retinal tears or treats neovascular lesions to prevent progression.
• Pneumatic Retinopexy: Injection of a gas bubble to tamponade a small retinal break; often combined with laser.
• Scleral Buckling: Placement of a silicone band around the eye to indent the wall and support the detached retina.
• Pars Plana Vitrectomy (PPV): Removal of the vitreous gel, repair of retinal tears, and removal of blood or scar tissue. The most common surgery for complex retinal detachments, proliferative diabetic retinopathy, and certain macular conditions.
• Epiretinal Membrane (ERM) peeling: Microscopic removal of scar tissue on the retinal surface to improve vision.

Lifestyle and Supportive Measures

• Control systemic risk factors (blood pressure, cholesterol, smoking cessation).
• Maintain regular eye‑exam schedule—at least annually for adults > 50, more often for diabetics.
• Protect eyes from trauma (e.g., safety glasses during sports).

Living with Vitreoretinal Disorders

Adapting daily life can improve safety, comfort, and visual function.

Vision‑assistive Strategies

• High‑contrast lighting: Use bright, evenly spaced lights to reduce glare.
• Magnifiers and low‑vision aids: Handheld or electronic devices for reading and detailed work.
• Adaptive technology: Screen‑reading software, voice‑controlled devices, and smartphone accessibility features.
• Rehabilitation counseling: Occupational therapy can teach orientation and mobility skills.

Eye‑care Routine

• Adhere to follow‑up appointments; many conditions need monitoring every 3‑6 months.
• Report any new floaters, flashes, or vision loss immediately.
• Keep a symptom diary—note timing, circumstances, and severity.
• Practice good ocular hygiene after intravitreal injections (avoid rubbing the eye, use prescribed antibiotic drops if advised).

Psychosocial Support

A sudden change in vision can be emotionally challenging. Consider joining support groups, counseling, or online communities (e.g., Retina Foundation of the Blind, American Macular Degeneration Foundation).

Prevention

While age‑related changes cannot be stopped, many modifiable factors can lower the risk of serious vitreoretinal disease.

• Control diabetes: Regular monitoring, medication adherence, diet, and exercise.
• Manage blood pressure and cholesterol: Reduces vascular stress on retinal vessels.
• Quit smoking: Lowers risk of AMD, diabetic retinopathy, and retinal detachment.
• Protect against eye injury: Wear protective eyewear during high‑risk activities.
• Annual comprehensive dilated eye exam: Early detection of peripheral retinal tears before they progress.
• Limit excessive near‑work and screen time: Take the 20‑20‑20 rule (every 20 minutes, look at something 20 feet away for 20 seconds) to reduce eye strain.

Complications

If left untreated, vitreoretinal disorders can lead to permanent visual impairment.

• Permanent retinal detachment: Results in irreversible loss of photoreceptors.
• Proliferative vitreoretinopathy (PVR): Scar tissue contracts, causing recurrent detachment even after surgery.
• Macular edema: Fluid accumulation at the central retina, leading to central vision loss.
• Neovascular glaucoma: Abnormal vessels grow on the iris, raising intra‑ocular pressure.
• Vision‑related anxiety or depression: Reduced quality of life and functional independence.

When to Seek Emergency Care

---

Sources: Mayo Clinic, 2024; Centers for Disease Control and Prevention (CDC), 2023; National Eye Institute (NEI), 2022; American Academy of Ophthalmology (AAO) Clinical Guidelines; CDC – Diabetic Retinopathy; WHO – Vision Health.

```